Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Cosmet Sci ; 37(6): 636-41, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26032853

ABSTRACT

OBJECTIVE: To examine the potential of non-animal collagens as a new option for cosmetic applications. METHODS: Non-animal collagens from three species, Streptococcus pyogenes, Solibacter usitatus and Methylobacterium sp 4-46, have been expressed as recombinant proteins in Escherichia coli using a cold-shock, pCold, expression system. The proteins were purified using either metal affinity chromatography or a simple process based on precipitation and proteolytic digestion of impurities, which is suitable for large-scale production. Samples were examined using a range of analytical procedures. RESULTS: Analyses by gel electrophoresis and mass spectrometry were used to examine the purity and integrity of the products. Circular dichroism spectroscopy showed stabilities around 38°C, and calculated pI values were from 5.4 to 8.6. UV-visible light spectroscopy showed the clarity of collagen solutions. The collagens were soluble at low ionic strength between pH 5 and pH 8, but were less soluble under more acidic conditions. At lower pH, the insoluble material was well dispersed and did not form the fibrous associations and aggregates found with animal collagens. The materials were shown to be non-cytotoxic to cells in culture. CONCLUSIONS: These novel, non-animal collagens may be potential alternatives to animal collagens for inclusion in cosmetic formulations.


Subject(s)
Acidobacteria/chemistry , Collagen/chemistry , Cosmetics , Methylobacterium/chemistry , Streptococcus pyogenes/chemistry
2.
Biochem J ; 350 Pt 3: 741-6, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-10970787

ABSTRACT

munc18c is a critical protein involved in trafficking events associated with syntaxin 4 and which also mediates inhibitory effects on vesicle docking and/or fusion. To investigate the domains of munc18c responsible for its interaction with syntaxin 4, fragments of munc18c were generated and their interaction with syntaxin 4 examined in vivo by the yeast two-hybrid assay. In vitro protein-protein interaction studies were then used to confirm that the interaction between the proteins was direct. Full-length munc18c(1-592), munc18c(1-139) and munc18c(1-225), but not munc18c(226-592), munc18c(1-100), munc18c(43-139) or munc18c(66-139), interacted with the cytoplasmic portion of syntaxin 4, Stx4(2-273), as assessed by yeast two-hybrid assay of growth on nutritionally deficient media and by beta-galactosidase reporter induction. The N-terminal predicted helix-a-helix-b-helix-c region of syntaxin 4, Stx4(29-157), failed to interact with full-length munc18c(1-592), indicating that a larger portion of syntaxin 4 is necessary for the interaction. The yeast two-hybrid results were confirmed by protein-protein interaction studies between Stx4(2-273) and glutathione S-transferase fusion proteins of munc18c. Full-length munc18c(1-592), munc18c(1-139) and munc18c(1-225) interacted with Stx4(2-273) whereas munc18c(1-100) did not, consistent with the yeast two-hybrid data. These data thus identify a region of munc18c between residues 1 and 139 as a minimal domain for its interaction with syntaxin 4.


Subject(s)
Membrane Proteins/metabolism , Nerve Tissue Proteins , Proteins/metabolism , Vesicular Transport Proteins , Animals , Base Sequence , Binding Sites , DNA Primers , Mice , Munc18 Proteins , Protein Binding , Proteins/chemistry , Qa-SNARE Proteins , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Two-Hybrid System Techniques , beta-Galactosidase/metabolism
3.
Biochem J ; 324 ( Pt 1): 217-24, 1997 May 15.
Article in English | MEDLINE | ID: mdl-9164859

ABSTRACT

Insulin stimulation of glucose transport in the major insulin-responsive tissues results predominantly from the translocation to the cell surface of a particular glucose transporter isoform, GLUT4, residing normally under basal conditions in intracellular vesicular structures. Recent studies have identified the presence of vesicle-associated membrane protein (VAMP) 2, a protein involved in vesicular trafficking in secretory cell types, in the vesicles of insulin-sensitive cells that contain GLUT4. The plasma membranes of insulin-responsive cells have also been shown to contain syntaxin 4 and the 25 kDa synaptosome-associated protein (SNAP-25), two proteins that form a complex with VAMP 2. The potential functional involvement of VAMP 2, SNAP-25 and syntaxin 4 in the trafficking of GLUT4 was assessed in the present study by determining the effect on GLUT4 translocation of microinjection of toxins that specifically cleave VAMPs or SNAP-25, or microinjection of specific peptides from VAMP 2 and syntaxin 4. Microinjection of tetanus toxin light chain or botulinum D toxin light chain resulted in an 80 and 61% inhibition respectively of insulin stimulation of GLUT4 translocation in 3T3L1 cells assessed using the plasma-membrane lawn assay. Botulinum A toxin light chain, which cleaves SNAP-25, was without effect. Microinjection of an N-terminal VAMP 2 peptide (residues 1-26) inhibited insulin stimulation of GLUT4 translocation by 54%. A syntaxin 4 peptide (residues 106-122) inhibited insulin stimulation of GLUT4 translocation by 40% whereas a syntaxin 1c peptide (residues 226-260) was without effect. These data taken together strongly suggest a role for VAMP 2 in GLUT4 trafficking and also for syntaxin 4. They further indicate that the isoforms of SNAP-25 isolated to date that are sensitive to cleavage by botulinum A toxin light chain do not appear to be involved in GLUT4 translocation.


Subject(s)
Insulin/pharmacology , Membrane Proteins/metabolism , Monosaccharide Transport Proteins/metabolism , Muscle Proteins , Protein Processing, Post-Translational/drug effects , Vesicular Transport Proteins , 3T3 Cells , Amino Acid Sequence , Animals , Botulinum Toxins/administration & dosage , Botulinum Toxins/pharmacology , Cell Membrane/metabolism , Glucose Transporter Type 4 , Guanosine 5'-O-(3-Thiotriphosphate)/administration & dosage , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Kinetics , Membrane Proteins/chemistry , Mice , Microinjections , Molecular Sequence Data , Nerve Tissue Proteins/metabolism , Peptide Fragments/administration & dosage , Peptide Fragments/chemical synthesis , Peptide Fragments/pharmacology , Qa-SNARE Proteins , R-SNARE Proteins , SNARE Proteins , Synaptosomal-Associated Protein 25 , Tetanus Toxin/administration & dosage , Tetanus Toxin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...